BRAIN Biotech AG announced earnings results for the second quarter ended March 31, 2021. For the second quarter, the company announced total revenue was EUR 11.311 million compared to EUR 9.799 million a year ago. Operating income was EUR 960,000 compared to EUR 1.422 million a year ago. Net income was EUR 2.070 million compared to net loss of EUR 2.494 million a year ago. Basic earnings per share from continuing operations was EUR 0.1 compared to basic loss per share from continuing operations of EUR 0.14 a year ago. For the half year, total revenue was EUR 19.799 million compared to EUR 20.190 million a year ago. Operating income was EUR 3.452 million compared to EUR 2.608 million a year ago. Net loss was EUR 1.286 million compared to EUR 4.752 million a year ago. Basic loss per share from continuing operations was EUR 0.06 compared to EUR 0.26 a year ago.